Anika Therapeutics Reiterates 2024 Guide, Cuts Costs
The company's orthopedic sales grew in the mid-single-digits during 1Q24 as the company reduced headcount to control costs. May 14, 2024
Vericel Keeps Momentum Ahead of MACI Arthro Launch
The company's MACI sales grew nearly 18% in the first quarter of 2024 with the launch of MACI Arthro expected in the third quarter. May 14, 2024
Paragon 28 Takes Sequential Step Up in Record Quarter
The company grew more than 17% in the first quarter of 2024 despite a difficult comparison and one less selling day. May 13, 2024
Treace Medical Reduces 2024 Guide on Competitive Headwinds
The company grew more than 20% in the first quarter of 2024 but lowered its full-year guidance due to increased competitive headwinds. May 13, 2024
ATEC Sees Market Disruption As Long Tail Growth Driver
The company grew 27% in the first quarter of 2024 as it further capitalized on disruption in the spine market. May 10, 2024
Bioventus Opens 2024 With Strong Growth Across Biologics Businesses
The company drove strong results for its non-surgical hyaluronic acid pain treatments and surgical bone graft substitutes. May 10, 2024
Orthofix Medical Delivering on Key Priorities to Start 2024
The company grew in the high single digits for the first quarter of 2024, including above-market growth in the United States. May 09, 2024
Globus Medical Completes First Quarter As Integrated Organization
The combined company integrated its field organizations during the first quarter and drove low-single-digit pro forma growth. May 09, 2024
SI-BONE Celebrates 100k Procedures Amid Strong Q1
The company grew in the mid-teens for the first quarter as it surpassed the 100,000 completed procedures milestone. May 07, 2024
BONESUPPORT Solidifies CERAMENT Platform With New Approvals
The company grew 54% in the first quarter of 2024 as CERAMENT continues to attract new customers and further penetrate existing accounts. May 06, 2024
